Ticker
BDTXCompany Name
BLACK DIAMOND THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 166.38M | $ 16.97M | 10.2% |
3/31/2025 | $ 176.25M | $ 17.88M | 10.15% |
12/31/2024 | $ 122.64M | $ 18.78M | 15.31% |
9/30/2024 | $ 137.9M | $ 19.67M | 14.26% |
6/30/2024 | $ 149.99M | $ 20.53M | 13.69% |
3/31/2024 | $ 142.52M | $ 21.36M | 14.99% |
12/31/2023 | $ 158.57M | $ 22.18M | 13.99% |
9/30/2023 | $ 172.38M | $ 23M | 13.34% |
6/30/2023 | $ 119.88M | $ 23.78M | 19.84% |
3/31/2023 | $ 135.58M | $ 24.55M | 18.1% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for BLACK DIAMOND THERAPEUTICS INC is calculated as follows: Debt [ $ 7.75M ] / Assets [ $ 346.44M ]
(=) Debt to Assets [ 2.24% ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.34% |
median | 21.09% |
std | 24.52% |